Medleaf High CBD Oil
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
11-01-2021
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
cannabidiol, Quantity: 100 mg/mL
Available from:
Epsilon Pharma Pty Ltd
Pharmaceutical form:
Oral Liquid
Composition:
Excipient Ingredients: medium chain triglycerides
Administration route:
Oral
Therapeutic indications:
Chronic Pain Anxiety Insomnia
Product summary:
Visual Identification: Oral liquid in a type 3 amber glass bottle with a child resistant, tamper evident dropper assembly.; Container Type: Bottle; Container Material: Glass Type III Coloured; Container Life Time: 3 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Authorization status:
Listed (Export Only)
Authorization date:
2020-11-09
